Skip To Main Content
Autumn D. Zuckerman on Muck Rack

Autumn D. Zuckerman

As seen in: PLOS, JAMA (The Journal of the American Medical Association), Health Affairs, Dove Medical Press, The American Journal of Medicine, The Journal of Allergy & Clinical Immunology, Journal of the American Pharmacists Association, Pharmacy Practice News, Multiple Sclerosis and Related Disorders
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Autumn D.

Contact Autumn D., search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Racial and Socioeconomic Differences in Real-World Use of Biologic Therapy for Asthma

|
By Monica Littlejohn, Autumn D. Zuckerman, Nicolas Gargurevich
| Dove Medical Press
Back to Journals » Journal of Asthma and Allergy » Volume 19 Authors Littlejohn M , Zuckerman AD , Gargurevich N, Choi L, Lubwama R , Stanford RH , Campbell C, Nunez M, Petruski-Ivleva N, Tardy AL, Cruchelow K Received 27 December 2025 Accepted for publication 4 May 2026 Published 5 June 2026 Volume 2026:19 587574 DOI https://doi.org/10.2147/JAA.S587574 Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 2 Editor who approved publication: Dr Luis...
Open in Who Shared Issue with article?

Deprescribing 5-Aminosalicytes in patients with ulcerative colitis on | PPA

|
By Kemberlee Bonnet, Autumn D. Zuckerman, David G Schlundt, Katie R Cruchelow
| Dove Medical Press
Authors Cruchelow KR, Bonnet KR , Zuckerman AD , Schlundt DG , Horst SN Received 7 November 2024 Accepted for publication 11 April 2025 Published 8 May 2025 Volume 2025:19 Pages 1351—1364 DOI https://doi.org/10.2147/PPA.S501049 Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 2 Editor who approved publication: Dr Michael Ortiz Katie R Cruchelow,1 Kemberlee R Bonnet,2 Autumn D Zuckerman,1 David G Schlundt,2 Sara N Horst3 1Vanderbilt Specialty Pharmacy,...
Open in Who Shared Issue with article?

HSSPs Avoid Unnecessary Costs Through Meaningful Interventions

|
By Autumn D. Zuckerman
| Pharmacy Practice News Verified
Director, Health Outcomes and Research Vanderbilt Specialty Pharmacy Nashville, Tennessee Specialty medications exceeded half of overall drug expenditures in 2022, and make up the largest portion of drugs forecasted to reach the market in 2023.1 Specialty medications are therapies used to treat complex and often chronic conditions such as cancer, rheumatoid arthritis, inflammatory bowel disease, and multiple sclerosis.
Open in Who Shared Issue with article?
See all 12 articles